...
首页> 外文期刊>Frontiers in Cellular Neuroscience >Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders
【24h】

Introducing directly induced microglia-like (iMG) cells from fresh human monocytes: a novel translational research tool for psychiatric disorders

机译:从新鲜的人类单核细胞中引入直接诱导的小胶质细胞样(iMG)细胞:精神疾病的新型转化研究工具

获取原文
           

摘要

Microglia, glial cells with immunological functions, have been implicated in various neurological diseases and psychiatric disorders in rodent studies, and human postmortem and PET studies. However, the deeper molecular implications of living human microglia have not been clarified. Here, we introduce a novel translational research approach focusing on human microglia. We have recently developed a new technique for creating induced microglia-like (iMG) cells from human peripheral blood. Two cytokines, GM-CSF and IL-34, converted human monocytes into the iMG cells within 14 days, which show various microglial characterizations; expressing markers, forming a ramified morphology, and phagocytic activity with various cytokine releases. We have already confirmed the applicability of this technique by analyzing iMG cells from a patient of Nasu-Hakola disease (NHD; Ohgidani et al., 2014 ). We herein show possible applications of the iMG cells in translational research. We believe that this iMG technique will open the door to explore various unknown dynamic aspects of human microglia in psychiatric disorders. This also opens new routes for psychopharmacological approach such as drug efficacy screening and personalized medicine.
机译:小胶质细胞,具有免疫功能的神经胶质细胞,已在啮齿动物研究以及人类死后和PET研究中与多种神经系统疾病和精神疾病有关。然而,人类的小胶质细胞的更深层次的分子含义尚未阐明。在这里,我们介绍一种针对人类小胶质细胞的新型转化研究方法。我们最近开发了一种新技术,可以从人外周血中创建诱导的小胶质细胞样(iMG)细胞。两种细胞因子GM-CSF和IL-34在14天内将人单核细胞转化为iMG细胞,显示出各种小胶质细胞特征。表达标记,形成分叉的形态,并具有各种细胞因子释放的吞噬活性。我们已经通过分析来自Nasu-Hakola病患者的iMG细胞证实了该技术的适用性(NHD; Ohgidani等,2014)。我们在本文中显示了iMG细胞在翻译研究中的可能应用。我们相信,这种iMG技术将为探索精神疾病中人类小胶质细胞的各种未知动态方面打开大门。这也为心理药理学方法开辟了新途径,例如药物功效筛查和个性化药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号